Clinical Outcomes of Endoscopic Resection for Treating WHYX Lesion

Samsung Medical Center

Status and phase: Completed; Phase 4

Conditions: WHYX Lesion; Extremely Well Differentiated Intestinal-type Adenocarcinoma

Treatments: Procedure: WHYX cancer group

Study type: Interventional

Funder types: Other

Identifiers

NCT01451034

2011-08-022

Details and patient eligibility

About

Endoscopically, WHYX cancers demonstrated a vague extent of tumor spread due to pale color changes in both the background atrophic and metaplastic gastric mucosa. However, the clinical outcomes of WHYX cancers after endoscopic resection are unknown. The aim of this study was to evaluate clinical outcomes of WHYX cancers after endoscopic resection.

Enrollment: 872 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• From January 2009 to December 2010 enrolled 872 patients with EGC

Exclusion criteria

• EGC with regional lymph node metastasis in radiologic finding endoscopically suspicious submucosal invasion

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

872 participants in 2 patient groups, including a placebo group

WHYX cancer group

Active Comparator group

Description:

WHYX cancer diagnosed by pathologic report

Treatment:

Procedure: WHYX cancer group

non-WHYX cancer group

Placebo Comparator group

Description:

all cancer except WHYX cancer diagnosed by pathologic report

Treatment:

Procedure: WHYX cancer group